Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Mithra Pharmaceuticals SA (BR: MITRA)

 
MITRA Technical Analysis
5
As on 11th Jul 2023 MITRA STOCK Price closed @ 1.99 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.89 & Strong Sell for SHORT-TERM with Stoploss of 16.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MITRASTOCK Price

Open 1.97 Change Price %
High 2.00 1 Day 0.02 1.02
Low 1.97 1 Week 0.00 0.00
Close 1.99 1 Month -0.34 -14.59
Volume 98791 1 Year -18.06 -90.07
52 Week High 21.10 | 52 Week Low 1.95
 
BR Belgium Most Active Stocks
BOTHE 0.29 70.59%
ABI 50.92 0.47%
ACPH 0.89 0.00%
KBC 66.02 2.36%
UMI 26.30 2.94%
PROX 7.06 0.14%
OPTI 0.02 %
BPOST 4.33 3.10%
WDP 26.58 1.22%
EURN 14.06 2.33%
 
BR Belgium Top Gainers Stocks
BOTHE 0.29 70.59%
UPG 3.84 14.97%
QRF 10.20 3.66%
MOUR 352.00 3.53%
ANT 6.41 3.22%
ANT 6.41 3.22%
HYL 11.30 3.20%
ZEN 198.00 3.12%
ZEN 198.00 3.12%
ZEN 198.00 3.12%
 
BR Belgium Top Losers Stocks
BELR 1.93 -74.27%
BELR 1.93 -74.27%
NEWT 1.80 -9.55%
NEWT 1.80 -9.55%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
ECONB 2.56 -3.40%
BCART 0.35 -2.78%
BEFB 46.10 -2.54%
 
 
MITRA
Daily Charts		 MITRA
Intraday Charts		 Whats New @
Bazaartrend		 MITRA
Free Analysis
 
MITRA Important Levels Intraday
RESISTANCE2.05
RESISTANCE2.03
RESISTANCE2.02
RESISTANCE2.01
SUPPORT1.97
SUPPORT1.96
SUPPORT1.95
SUPPORT1.93
 
MITRA Forecast April 2024
Share
4th UP Forecast16.44
3rd UP Forecast11.81
2nd UP Forecast8.94
1st UP Forecast6.08
1st DOWN Forecast-2.1
2nd DOWN Forecast-4.96
3rd DOWN Forecast-7.83
4th DOWN Forecast-12.46
 
MITRA Weekly Forecast
4th UP Forecast6.02
3rd UP Forecast4.73
2nd UP Forecast3.93
1st UP Forecast3.13
1st DOWN Forecast0.85
2nd DOWN Forecast0.05
3rd DOWN Forecast-0.75
4th DOWN Forecast-2.04
 
MITRA Forecast2024
4th UP Forecast39.43
3rd UP Forecast27.42
2nd UP Forecast20
1st UP Forecast12.58
1st DOWN Forecast-8.6
2nd DOWN Forecast-16.02
3rd DOWN Forecast-23.44
4th DOWN Forecast-35.45
 
 
MITRA Other Details
Segment EQ
Market Capital 831879680.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
MITRA Address
MITRA
 
MITRA Latest News
 
Your Comments and Response on Mithra Pharmaceuticals SA
 
MITRA Business Profile
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for vasomotor menopausal symptoms relief; and PeriNesta, an oral treatment for perimenopause. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium. Address: Rue Saint-Georges 5, Liège, Belgium, 4000
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service